Related Experiment Videos
Prognostic criteria in nonfunctioning pancreatic endocrine tumours
S La Rosa1, F Sessa, C Capella
1Department of Clinical and Biological Sciences, University of Pavia at Varese, Italy.
Virchows Archiv : an International Journal of Pathology
|December 1, 1996
Summary
This study identified four prognostic groups for non-functioning pancreatic endocrine tumors. Vascular microinvasion and Ki67 index are key predictors of malignancy risk and patient survival.
Area of Science:
- Oncology
- Pathology
- Endocrinology
Background:
- Non-functioning pancreatic endocrine tumors (NF-PETs) lack clear clinical presentation, necessitating better prognostic tools.
- Accurate prognostication is crucial for guiding treatment and predicting outcomes in NF-PET patients.
Purpose of the Study:
- To define prognostic subgroups within non-functioning pancreatic endocrine tumors.
- To identify histopathological and immunohistochemical markers predictive of malignancy and patient survival.
Main Methods:
- Systematic analysis of 61 NF-PETs for macroscopic, histopathological, and immunohistochemical variables.
- Utilized nuclear atypia, mitotic rate, necrosis, Ki67 index, vascular/perineural microinvasion, tumor size, and receptor status for stratification.
- Correlated identified variables with malignancy and patient survival outcomes.
Main Results:
- Separated tumors into poorly differentiated carcinomas (5) and well-differentiated tumors (56).
- Identified 29 well-differentiated carcinomas with local invasion or metastases.
- Vascular microinvasion and Ki67 index > 2% were highly sensitive and specific predictors of malignancy.
- Stratified remaining tumors into increased-risk (11) and limited-risk (16) groups based on these predictors.
- Established four distinct prognostic groups with significantly different survival curves.
Conclusions:
- Vascular microinvasion and Ki67 proliferative index are critical prognostic indicators for NF-PETs.
- The proposed four-group classification (limited-risk, increased-risk, well-differentiated carcinoma, poorly differentiated carcinoma) aids in risk stratification and outcome prediction.
- These findings improve the understanding and management of non-functioning pancreatic endocrine tumors.